| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.72B | 10.55B | 9.59B | 8.86B | 8.17B |
| Gross Profit | 3.60B | 3.54B | 3.18B | 2.88B | 2.38B |
| EBITDA | 2.15B | 2.12B | 1.77B | 1.66B | 1.40B |
| Net Income | 1.46B | 1.43B | 1.16B | 1.10B | 1.13B |
Balance Sheet | |||||
| Total Assets | 4.46B | 4.71B | 3.54B | 4.61B | 3.42B |
| Cash, Cash Equivalents and Short-Term Investments | 1.43B | 1.83B | 828.37M | 39.39M | 468.96M |
| Total Debt | 302.72M | 102.89M | 0.00 | 0.00 | 10.32M |
| Total Liabilities | 1.65B | 1.30B | 1.28B | 1.22B | 1.02B |
| Stockholders Equity | 2.81B | 3.41B | 2.26B | 3.39B | 2.40B |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 1.27B | 819.23M | 891.40M | 385.37M |
| Operating Cash Flow | 0.00 | 1.37B | 1.15B | 1.24B | 587.77M |
| Investing Cash Flow | 0.00 | -180.24M | 1.92B | -1.54B | -1.15B |
| Financing Cash Flow | 0.00 | -187.01M | -2.29B | -126.32M | -26.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥59.55B | 37.23 | ― | 2.74% | ― | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥1.42B | 9.98 | ― | ― | -10.98% | ― | |
56 Neutral | ¥1.08B | -4.99 | ― | ― | 39.34% | -765.51% | |
54 Neutral | ¥3.98B | -20.19 | ― | ― | 11.96% | -453.36% | |
44 Neutral | ¥1.62B | -34.47 | ― | 0.42% | 6.81% | 62.28% |
Mamezo Co., Ltd. reported a significant increase in its financial performance for the six months ending September 30, 2025, with net sales and profits showing notable year-on-year growth. The company plans to merge its three wholly-owned subsidiaries and transition to non-consolidated financial statements, which is expected to impact its future financial reporting and operations.